88 related articles for article (PubMed ID: 6327590)
1. Muraceins--muramyl peptides produced by Nocardia orientalis as angiotensin-converting enzyme inhibitors. I. Taxonomy, fermentation and biological properties.
Bush K; Henry PR; Slusarchyk DS
J Antibiot (Tokyo); 1984 Apr; 37(4):330-5. PubMed ID: 6327590
[TBL] [Abstract][Full Text] [Related]
2. Muraceins--muramyl peptides produced by Nocardia orientalis as angiotensin-converting enzyme inhibitors. II. Isolation and structure determination.
Singh PD; Johnson JH
J Antibiot (Tokyo); 1984 Apr; 37(4):336-43. PubMed ID: 6327591
[TBL] [Abstract][Full Text] [Related]
3. Biological properties of angiotensin-converting enzyme inhibitor derived from tuna muscle.
Kohama Y; Oka H; Matsumoto S; Nakagawa T; Miyamoto T; Mimura T; Nagase Y; Satake M; Takane T; Fujita T
J Pharmacobiodyn; 1989 Sep; 12(9):566-71. PubMed ID: 2614645
[TBL] [Abstract][Full Text] [Related]
4. Phenacein--an angiotensin-converting enzyme inhibitor produced by a streptomycete. I. Taxonomy, fermentation and biological properties.
Bush K; Henry PR; Souser-Woehleke M; Trejo WH; Slusarchyk DS
J Antibiot (Tokyo); 1984 Nov; 37(11):1308-12. PubMed ID: 6096340
[TBL] [Abstract][Full Text] [Related]
5. Contractile effects of bacterial cell walls, their enzymatic digests, and muramyl dipeptides on ileal strips from guinea pigs.
Ogawa T; Kotani S; Tsujimoto M; Kusumoto S; Shiba T; Kawata S; Yokogawa K
Infect Immun; 1982 Feb; 35(2):612-9. PubMed ID: 7056578
[TBL] [Abstract][Full Text] [Related]
6. Smooth muscle stimulation by an immunomodulatory compound muramyl dipeptide: does it involve serotoninergic system?
Kadlec O; Masek K; Gulda O; Růzicka V; Parant M; Chedid L
Pharmacology; 1984; 29(1):31-9. PubMed ID: 6146991
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and pharmacological screening of new angiotensin converting enzyme inhibitors.
Gubert S; Braso MA; Sacristán A; Ortiz JA
Farmaco; 1990 Jan; 45(1):59-79. PubMed ID: 2186741
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological properties of the new non-sulfhydryl angiotensin converting enzyme inhibitor N-[8-amino-1(S)-carboxyoctyl]-L-alanyl-L-proline.
Shirota M; Kajiwara Y; Iijima M; Kitabatake K
Arzneimittelforschung; 1990 May; 40(5):515-9. PubMed ID: 2166521
[TBL] [Abstract][Full Text] [Related]
9. K-13, a novel inhibitor of angiotensin I converting enzyme produced by Micromonospora halophytica subsp. exilisia. I. Fermentation, isolation and biological properties.
Kase H; Kaneko M; Yamada K
J Antibiot (Tokyo); 1987 Apr; 40(4):450-4. PubMed ID: 3034844
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of angiotensin converting enzyme and potentiation of bradykinin by retro-inverso analogues of short peptides and sequences related to angiotensin I and bradykinin.
Carmona AK; Juliano L
Biochem Pharmacol; 1996 Apr; 51(8):1051-60. PubMed ID: 8866827
[TBL] [Abstract][Full Text] [Related]
11. Do the cardiovascular effects of angiotensin-converting enzyme (ACE) I involve ACE-independent mechanisms? new insights from proline-rich peptides of Bothrops jararaca.
Ianzer D; Santos RA; Etelvino GM; Xavier CH; de Almeida Santos J; Mendes EP; Machado LT; Prezoto BC; Dive V; de Camargo AC
J Pharmacol Exp Ther; 2007 Aug; 322(2):795-805. PubMed ID: 17475904
[TBL] [Abstract][Full Text] [Related]
12. Species variability for toxicity of free and liposome-encapsulated muramyl peptides administered intravenously.
Fidler IJ; Brown NO; Hart IR
J Biol Response Mod; 1985 Jun; 4(3):298-309. PubMed ID: 4020387
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological and toxicological studies of the new angiotensin converting enzyme inhibitor moexipril hydrochloride.
Friehe H; Ney P
Arzneimittelforschung; 1997 Feb; 47(2):132-44. PubMed ID: 9079232
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological activity of a ketomethylene analogue of a tripeptide inhibitor of angiotensin converting enzyme.
Almquist RG; Chao WR; Ellis ME; Johnson HL
J Med Chem; 1980 Dec; 23(12):1392-8. PubMed ID: 6256550
[TBL] [Abstract][Full Text] [Related]
15. Biologically active peptides from Bothrops jararacussu venom.
Ferreira LA; Henriques OB; Lebrun I; Batista MB; Prezoto BC; Andreoni AS; Zelnik R; Habermehl G
Agents Actions Suppl; 1992; 36():209-14. PubMed ID: 1609644
[TBL] [Abstract][Full Text] [Related]
16. Demonstration of extrapulmonary activity of angiotensin converting enzyme in intact tissue preparations.
Lembeck F; Griesbacher T; Eckhardt M
Br J Pharmacol; 1990 May; 100(1):49-54. PubMed ID: 2164861
[TBL] [Abstract][Full Text] [Related]
17. N-demethylvancomycin, a novel antibiotic produced by a strain of Nocardia orientalis. Taxonomy and fermentation.
Boeck LD; Mertz FP; Wolter RK; Higgens CE
J Antibiot (Tokyo); 1984 May; 37(5):446-53. PubMed ID: 6547432
[TBL] [Abstract][Full Text] [Related]
18. [Synthesis and biological activity of analogs of a nonapeptide inhibitor of peptidyldipeptidase].
Filatova MP; Krit NA; Beschastnaia NV; Blokhina AV; Kozlova NI
Bioorg Khim; 1985 Jan; 11(1):21-30. PubMed ID: 2985089
[TBL] [Abstract][Full Text] [Related]
19. The C-type natriuretic peptide precursor of snake brain contains highly specific inhibitors of the angiotensin-converting enzyme.
Hayashi MA; Murbach AF; Ianzer D; Portaro FC; Prezoto BC; Fernandes BL; Silveira PF; Silva CA; Pires RS; Britto LR; Dive V; Camargo AC
J Neurochem; 2003 May; 85(4):969-77. PubMed ID: 12716428
[TBL] [Abstract][Full Text] [Related]
20. Characterization of angiotensin II formation in human isolated bladder by selective inhibitors of ACE and human chymase: a functional and biochemical study.
Waldeck K; Lindberg BF; Persson K; Andersson KE
Br J Pharmacol; 1997 Jul; 121(6):1081-6. PubMed ID: 9249242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
